mHealth Insulin Titration and Management (iSage)



Status:Recruiting
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:21 - Any
Updated:2/24/2019
Start Date:August 28, 2018
End Date:March 2020
Contact:Teri Lavenbarg, MSN, PNP-BC, FNP-BC, APRN, CDE
Email:tlavenbarg@kumc.edu
Phone:913-588-6022

Use our guide to learn which trials are right for you!

The purpose of this study is to determine the benefits of using the iSage app for basal
insulin titration and support. By doing this study the investigators hope to learn whether
the app improves the participant's ability to follow his/her healthcare provider's
instructions to adjust his/her insulin doses.


Inclusion Criteria:

- Diagnosed Type 2 Diabetes, based on the World Health Organization (WHO) criteria,
treated with basal insulin

- HbA1c 8-11% inclusive

- Glomerular filtration rate (GFR) > 60 ml/min

- Has an Android or iOS based compatible smartphone (iOS 9.0 or above, Android 4.4 or
above)

- Currently performs at least 3 fasting fingerstick glucose measurements per week

- Has a primary care physician (PCP) within the University of Kansas Health System

- English speaking

Exclusion Criteria:

- Diagnosis of hypoglycemic unawareness

- Diagnosis of hyperglycemic hyperosmolar non-ketotic coma (HONK) or diabetic
ketoacidosis (DKA) within 6 months of enrollment

- Recent (within the last 6 months)/current use of non-topical steroids

- Insulin requirements in excess of 1 U/kg per day

- Use of pioglitazone or another thiazolidinedione (TZD)

- In the opinion of the provider, HgbA1c goals should be adjusted above 7% due to
infirmity, unstable cardiovascular disease, etc.
We found this trial at
1
site
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
Principal Investigator: David Robbins, MD
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials